Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits
- 1 July 1987
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 31 (7) , 1075-1078
- https://doi.org/10.1128/aac.31.7.1075
Abstract
The pharmacokinetic disposition of vancomycin and ciprofloxacin was assessed in rabbits before the efficacy of these compounds in experimental staphylococcal endocarditis was compared. Ciprofloxacin was given in single intravenous bolus doses of 25 and 35 mg/kg and also in a multiple-dose regimen of 35 mg/kg every 6 h. Vancomycin was given in a similar manner in single doses of 17.5 and 25 mg/kg and in a multiple-dose regimen of 17.5 mg/kg every 6 h. Serum was sampled frequently after injections and analyzed by microbiologic assay for drug concentration. The pharmacokinetic parameters of clearance and steady-state volume of distribution were calculated by compartment-independent methods. These studies revealed that clearance of ciprofloxacin was reduced significantly after multiple doses (7.42 .+-. 0.85 [standard deviation] versus 6.09 .+-. 0.71 liters/h, P < 0.01). Although the half-life and volume of distribution increased after multiple dosing, the differences were not statistically significant. The disposition of vancomycin following single doses was significantly altered after the 25-mg/kg dose compared with the 17.5-mg/kg dose. Half-life, clearance, and volume of distribution changed from 1.27 .+-. 0.2 to 1.60 .+-. 0.21 h (P < 0.05), 0.54 .+-. 0.05 to 0.39 .+-. 0.04 liters/h (P < 0.01), and 0.37 .+-. 0.04 to 0.31 .+-. 0.03 liters/kg (P < 0.05), respectively. The disposition of ciprofloxacin was not altered with increases in dose size, and the disposition of vancomycin was not altered after multiple doses. If such alterations in the pharmacokinetic disposition of antimicrobial agents are unanticipated, the higher and more prolonged than expected serum concentrations may have an effect on the outcome of experimental infections.This publication has 17 references indexed in Scilit:
- Efficacy of ciprofloxacin for experimental endocarditis caused by methicillin-susceptible or -resistant strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- Experimental Infection with Streptococcus pneumoniae in Mice: Correlation of in Vitro Activity and Pharmacokinetic Parameters with in Vivo Effect for 14 CephalosporinsThe Journal of Infectious Diseases, 1986
- Tissue penetration of ciprofloxacin after single and multiple dosesAntimicrobial Agents and Chemotherapy, 1986
- Enoxacin compared with vancomycin for the treatment of experimental methicillin-resistant Staphylococcus aureus endocarditisAntimicrobial Agents and Chemotherapy, 1986
- Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microfloraAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo CorrelationsThe Journal of Infectious Diseases, 1985
- Pharmacokinetics of intravenously administered ciprofloxacinAntimicrobial Agents and Chemotherapy, 1984
- In-vitro studies with ciprofloxacin, a new 4-quinolone compoundJournal of Antimicrobial Chemotherapy, 1984
- Antibiotic Therapy of Experimental Staphylococcus epidermidis EndocarditisAntimicrobial Agents and Chemotherapy, 1980